Arrowhead Pharmaceuticals Inc (ARWR)

Number of days of payables

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Payables turnover		23.34	2.79	13.48	12.09	159.01	45.49	23.02	11.41	25.33	9.11	6.20	10.31	11.31	8.22	12.63	3.39	2.83	3.88	5.61	6.34
Number of days of payables	days	15.64	131.05	27.07	30.19	2.30	8.02	15.86	31.99	14.41	40.07	58.83	35.42	32.26	44.38	28.89	107.57	128.93	94.12	65.06	57.56

December 31, 2023 calculation

Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 23.34
= 15.64

Based on the data provided, it appears that the number of days of payables for Arrowhead Pharmaceuticals Inc. is not clearly indicated in the table for the given periods from Q2 2022 to Q1 2024. The specific data on the number of days of payables for these quarters is missing, making it challenging to perform a detailed analysis of this financial ratio.

It is advisable to ensure that the missing data for the number of days of payables is updated in the financial statements or provided separately to accurately assess the company's payment practices and liquidity management. Understanding the trend and changes in the number of days of payables would provide valuable insights into Arrowhead Pharmaceuticals Inc.'s relationship with its suppliers and its efficiency in managing its working capital.